These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9218074)

  • 1. Comparison of ranitidine and lansoprazole in short-term low-dose triple therapy for Helicobacter pylori infection.
    Kihira K; Satoh K; Saifuku K; Taniguchi Y; Takimoto T; Yamamoto H; Ido K; Yoshida Y; Kimura K
    Aliment Pharmacol Ther; 1997 Jun; 11(3):511-4. PubMed ID: 9218074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
    Spadaccini A; De Fanis C; Sciampa G; Russo L; Silla M; Pantaleone U; Di Virgilio M; Pizzicanella G
    Aliment Pharmacol Ther; 1998 Oct; 12(10):997-1001. PubMed ID: 9798805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
    Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
    Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
    Lazzaroni M; Bargiggia S; Bianchi Porro G
    Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M; Székely E; Illyés G; Széles I
    Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections].
    Kihira K; Sato K; Yoshida Y; Kumakura Y; Kimura K; Sugano K
    Nihon Rinsho; 1999 Jan; 57(1):148-52. PubMed ID: 10036953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection.
    Jaup BH; Norrby A
    Aliment Pharmacol Ther; 1996 Jun; 10(3):275-7. PubMed ID: 8791950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.
    Perri F; Festa V; Merla A; Quitadamo M; Clemente R; Andriulli A
    Helicobacter; 2002 Apr; 7(2):99-104. PubMed ID: 11966868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
    Spinzi GC; Bierti L; Bortoli A; Colombo E; Fertitta AM; Lanzi GL; Venturelli R; Minoli G
    Aliment Pharmacol Ther; 1998 May; 12(5):433-8. PubMed ID: 9663722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent eradication of Helicobacter pylori with dual therapy.
    Treiber G; Ammon S; Klotz U
    Aliment Pharmacol Ther; 1997 Aug; 11(4):711-8. PubMed ID: 9305480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
    Ahuja V; Dhar A; Bal C; Sharma MP
    Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
    Miwa H; Nagahara A; Sato K; Ohkura R; Murai T; Shimizu H; Watanabe S; Sato N
    J Gastroenterol Hepatol; 1999 Apr; 14(4):317-21. PubMed ID: 10207779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients.
    Takimoto T; Satoh K; Taniguchi Y; Saifuku K; Kihira K; Seki M; Yoshida Y; Ido K; Kimura K
    Helicobacter; 1997 Jun; 2(2):86-91. PubMed ID: 9432334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
    Harris AW; Misiewicz JJ; Bardhan KD; Levi S; O'Morain C; Cooper BT; Kerr GD; Dixon MF; Langworthy H; Piper D
    Aliment Pharmacol Ther; 1998 Aug; 12(8):741-5. PubMed ID: 9726387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
    Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
    Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection.
    Liu WZ; Xiao SD; Shi Y; Wu SM; Zhang DZ; Xu WW; Tytgat GN
    Aliment Pharmacol Ther; 1999 Mar; 13(3):317-22. PubMed ID: 10102964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
    Yousfi MM; El-Zimaity HM; Cole RA; Genta RM; Graham DY
    Aliment Pharmacol Ther; 1996 Feb; 10(1):119-22. PubMed ID: 8871452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.